GreenVision Acquisition Corp. (GRNV) Stock

About GreenVision Acquisition Corp.

GreenVision Acquisition Corp. is primarily focused on bringing about corporate combinations, utilizing methods such as mergers, stock exchanges, asset acquisitions, share purchases, or broader reorganizations with other entities. The company's strategic attention is directed towards businesses operating within the life sciences and healthcare sectors across North America, Europe, and Asia. Established in 2019, the firm's main office is located in New York, New York.

GreenVision Acquisition Corp. is headquartered in CN.

GreenVision Acquisition Corp. (GRNV) stock trades at $12.95 with a market capitalization of $3.79B. The stock is valued at a negative price-to-earnings (P/E) ratio of -610.85, reflecting a net loss over the last twelve months, a negative price-to-book of -31.82, reflecting negative shareholders' equity, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $7.70 and $25.30, and currently trades 48.8% below its 52-week high.

On profitability, GreenVision Acquisition Corp. generates a return on equity (ROE) of 5.03%, return on capital employed of 2.56%.